BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ox.ac.uk//NONSGML oxford.event//EN
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Engineered Nanobodies to Direct and Visualize Immune Tolerance
DTSTART;TZID=Europe/London:20260706T140000
DTEND;TZID=Europe/London:20260706T150000
DTSTAMP:20260615T010915Z
UID:b863c397-c93f-f111-88b5-7c1e52046c40
CREATED:20260424T103730Z
DESCRIPTION:Novalia (Nova) Pishesha grew up in Indonesia as the daughter o
 f toy shop owners with no formal high school education. Recognized early f
 or her academic talents\, she emigrated to the United States alone to purs
 ue higher education. Nova attended the University of California\, Berkeley
 \, on a full-ride scholarship and later earned her PhD in Biological Engin
 eering at MIT under the mentorship of Drs. Harvey Lodish and Hidde Ploegh.
  After PhD\, Nova was elected as a Junior Fellow at the Harvard Society of
  Fellows\, where she continued her research with Dr. Ploegh and received a
 dditional mentorship from Dr. Aviv Regev and Dr. Sangeeta Bhatia at the Br
 oad Institute and the Koch Institute\, respectively. Her work has laid the
  foundation for three biotech companies\, including Cerberus and Orthrus T
 herapeutics\, which she co-founded in 2022 and 2025\, respectively. Nova h
 as been honored with several awards\, including the MIT Technology Review
 ’s Innovators Under 35 (Asia Pacific) and the STAT+ Wunderkind by The Bo
 ston Globe. She is the recipient of the National Multiple Sclerosis Founda
 tion Career Transition Award\, the Rheumatology Research Foundation Innova
 tive Award\, and Breakthrough T1D Career Development Award. In January 202
 4\, she launched her own lab as an Assistant Professor in the Division of 
 Immunology at Boston Children’s Hospital and Harvard Medical School\, fo
 cusing on advancing immune engineering to combat pathogenic immunity and i
 nfectious diseases.
LAST-MODIFIED:20260424T103905Z
LOCATION:Sir William Dunn School of Pathology - EPA Seminar Room\, EPA Sem
 inar Room Sir William Dunn School of Pathology South Parks Road Oxford Oxf
 ordshire OX1 3RE United Kingdom
SPEAKER:Dr Novalia Pishesha (Division of Immunology at Boston Children's H
 ospital and Harvard Medical School)
END:VEVENT
END:VCALENDAR